1. Ming-Lun Yeh - Google Scholar
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. JF Huang, PC Tsai, ML Yeh, CF Huang, CI Huang, MH Hsieh ...
Kaohsiung Medical University Hospital - Cited by 4,205
2. Community-centered Disease Severity Assessment of Metabolic ...
24 mei 2023 · Despite a significantly lower body mass index (BMI) and lower rates of obesity compared to other ethnic groups, Asians have a significant ...
Disease severity across the different diagnostic categories of metabolic dysfunction-associated fatty liver disease (MAFLD) remains elusive. This study assessed the fibrosis stages and features of MAFLD between different items. We also aimed to investigate the associations between advanced fibrosis and risk factors.
3. 研究成果 - META Title
16 更新. 2024. Mei-Hsuan Lee, Yi-Ting Chen, Yu-Han Huang, Sheng-Nan Lu, Tsai-Hsuan Yang, Jee-Fu Huang, Szu-Ching Yin, Ming-Lun ... Body mass index (BMI) as a ...
2024
4. Program & Proceedings: HPH Conferences
... Yeh, Sung-Yun Chen, Yi-Fan Tsai. A Study of Behavior in the Residential ... BMI change on the development of Metabolic Syndrome after 5 years in ...
Poster Sessions 1
5. Less liver fibrosis marker increment in overweight chronic hepatitis B ...
Ming-Lun Yeh1,4,5,6,; Pei-Chien Tsai1,4,5,; Tyng-Yuan Jang3,5,; Jee-Fu Huang1 ... overweight or obese (BMI ≥25 kg/m2). View this table: View inline; View ...
Background and aims Chronic hepatitis B patients in Taiwan with no or limited liver injury are not reimbursed for antiviral treatment by the Taiwan National Health Insurance (NHI). Innovative fibrosis marker, age-adjusted Fibrosis-4 Index (FIB4-AA), was implemented to evaluate the tendency of liver fibrosis in these patients. Methods The FIB-4 indices of 256 antiviral treatment-naïve chronic hepatitis B patients at Kaohsiung Medical University Hospital from 2003 to 2019 were reviewed. The difference in initial FIB-4 and last FIB4-AA was treated as a categorical variable, representing the tendency of liver fibrosis in each individual aside from ageing. Logistic regression was implemented to evaluate the three parameters most dependent on increment of FIB4-A A : e seroconversion, body mass index (BMI) and initial FIB-4 index. Results The yearly FIB-4 growth rate of an individual without chronic hepatitis was lower than that of the study group (0.0237 vs 0.0273 for males, 0.02 vs 0.0288 for females). Patients undergoing or completing e seroconversion were less prone to increment of FIB4-AA (p=0.036, OR 0.524). Logistic regression revealed that BMI ≥25 kg/m2 significantly less increment of FIB4-AA (p=0.001, OR 0.383, 95% CI 0.212 to 0.690), while patients with initial FIB-4 <1.29 were prone to increasing liver FIB4-AA (p=0.000, OR 3.687, 95% CI 1.999 to 6.797). Conclusion Chronic hepatitis B patients not meeting the reimbursement criteria of the Taiwan NHI are prone to increme...
6. PNPLA3 genetic variants determine hepatic steatosis in non-obese ...
3 jul 2015 · PNPLA3 genetic variants had minimal effects on hepatic steatosis among overweight or obese patients. Compared to patients with BMI<24 kg/m2/non- ...
See AlsoRicki Lake CelebmafiaThe influence of patatin-like phospholipase domain-containing 3 (PNPLA3) genetic variants in the development of liver steatosis in Asian chronic hepatitis C patients remains elusive. A total of 1018 biopsy-proven chronic hepatitis C patients were enrolled for evaluation. The proportions of PNPLA3 rs738409 GG genotype carriage were 7.8% (44/563), 15.8% (58/367) and 19.3% (17/88) in patients with no (liver fat content <5%), mild (5–33%) and moderate/severe (>66%) hepatic steatosis, respectively (trend P < 0.001). Stepwise logistic regression analysis revealed that the strongest factor independently associated with steatosis was the carriage of the PNPLA3 rs738409 GG genotype (odds ratio [OR]/95% confidence intervals [CI]:2.34/1.557–3.515, P < 0.001). Among the patients with BMI < 24 kg/m2, carriage of the rs738409 GG genotype was the only factor associated with hepatic steatosis (OR/CI:3.44/1.824–6.500, P < 0.001). PNPLA3 genetic variants had minimal effects on hepatic steatosis among overweight or obese patients. Compared to patients with BMI<24 kg/m2/non-GG genotype, those with BMI>24 kg/m2/GG genotype were more likely to have hepatic steatosis (OR/CI:3.87/2.292–6.524, P < 0.001). In conclusions, both PNPLA3 genetic variants and BMI played important roles in hepatic steatosis among Asian chronic hepatitis C patients. However, the genetic effect was mainly restricted to non-obese patients.
7. Dynamic change of metabolic dysfunction-associated steatotic ...
Body mass index (BMI) (odds ratio [OR] 0.89; 95% confidence intervals [CI] ... AU - Ming-Lun Yeh AU - Ming-Yen Hsieh AU - Chao-Kuan Huang AU - Jee-Fu ...
Clinical and Molecular Hepatology, 2024, 30(4), 883
8. Prognostic prediction of left ventricular myocardial noncompaction using ...
MACE, major adverse cardiovascular event; BMI, body mass index; NYHA, New ... Yeh HY, Chen CY. XGBoost Improves Classification of MGMT Promoter ...
Prognostic prediction of left ventricular myocardial noncompaction using machine learning and cardiac magnetic resonance radiomics
9. [PDF] Factors Associated with Significant Platelet Count Improvement in ...
7 feb 2022 · ... Lun Yeh 10,19. , Chih-Lang Lin 20,. Chun-Yen Lin 21,22. , Pei-Lun Lee ... obese adipose tissue and metabolic syndrome. Med. Inflamm. 2013 ...
10. Itemization difference of patient-reported outcome in ... - PLOS
22 feb 2022 · Ming-Lun Yeh. Affiliations: Hepatobiliary Division, Department of ... obesity [22–24]. The decreased performance might be due to the ...
Background and aims The itemization difference of patient-reported outcome (PRO) in hepatitis patients with different etiologies remains elusive in Asia. We aimed to assess the characteristics and the difference of health-related quality of life (HRQoL) in chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD) patients. Methods We conducted the study in an outpatient setting. The 36-Item Short Form Health Survey (SF-36) was completed by the patients upon the initial diagnosis and recruitment for a long-term follow-up purpose. The PRO results were also assessed by disease severity. Results There were 244 patients (198 males) of CHB, 54 patients (29 males) of CHC, and 129 patients (85 males) of NAFLD, respectively. CHC patient had the mean score of 67.1 ± 23.3 in physical component summary (PCS) of the SF-36 health survey, which was significantly lower than CHB patients (76.4 ± 19.5), and NAFLD patients (77.5 ± 13.7), respectively (p = 0.001). The significantly lower performance of PCS in CHC patients was mainly attributed to the lower performance in physical functioning and bodily pain components. Higher fibrosis 4 index scores were significantly associated with lower PCS scores in all patient groups. There was no significant difference of mean mental component summary (MCS) between groups. However, NAFLD patients had significantly lower mental health scores than other groups (p = 0.02). Conclusions The significant difference...
11. Real-World Effectiveness From the Asia Pacific Rim Liver Consortium ...
Ming-Lun Yeh ,. Ming-Lun Yeh. Department of Internal Medicine, Kaohsiung Medical ... Longitudinal Change of Body Mass Index Is Associated With Alanine ...
12. Search - Cancer Research and Treatment
... Yeh Chuang, Yu-Da Lin IEEE Transactions on Fuzzy Systems.2021; 29(12): ... BMI on Age Hye Sim Kim, Tae Hwa Go, Dae Ryong Kang, Jae Hung Jung, Sung Won ...
Advanced Search
